1. Biomarkers in Primary Focal Segmental Glomerulosclerosis in Optimal Diagnostic-Therapeutic Strategy
   Aleksandra Musiała et al, 2022, Journal of Clinical Medicine CrossRef
2. Expression of DNA Damage Response Molecules PARP1, γH2AX, BRCA1, and BRCA2 Predicts Poor Survival of Breast Carcinoma Patients
   See-Hyoung Park et al, 2015, Translational Oncology CrossRef
3. Prognostic and clinicopathological value of poly (adenosine diphosphate-ribose) polymerase expression in breast cancer: A meta-analysis
   Weiqiang Qiao et al, 2017, PLOS ONE CrossRef
4. An Array SPRi Biosensor for the Determination on PARP-1 in Blood Plasma
   Zuzanna Zielinska et al, 2023, Biomedicines CrossRef
5. Quantitative analysis of biochemical processes in living cells at a single-molecule level: a case of olaparib–PARP1 (DNA repair protein) interactions
   Aneta Karpińska et al, 2021, The Analyst CrossRef
6. EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer
   H Yamaguchi et al, 2018, Oncogene CrossRef
7. Nuclear PARP1 expression and its prognostic significance in breast cancer patients
   Annalisa Mazzotta et al, 2016, Tumor Biology CrossRef
8. Poly(ADP-ribosylation) is present in murine sciatic nerve fibers and is altered in a Charcot-Marie-Tooth-1E neurodegenerative model
   Laura I. Lafon Hughes et al, 2017, PeerJ CrossRef
9. PARP1 Enhances Influenza A Virus Propagation by Facilitating Degradation of Host Type I Interferon Receptor
   Chuan Xia et al, 2020, Journal of Virology CrossRef
10. Expression of poly(Adenosine Diphosphate-Ribose) polymerase protein in breast cancer
    RamNiwas Meena et al, 2022, Journal of Mid-life Health CrossRef
11. The Prognostic Values of PARP-1 Expression in Uveal Melanoma
    Malgorzata Gajdzis et al, 2021, Cells CrossRef
12. SurvSHAP(t): Time-dependent explanations of machine learning survival models
    Mateusz Krzyziński et al, 2023, Knowledge-Based Systems CrossRef
13. Overexpression of PARP is an independent prognostic marker for poor survival in Middle Eastern breast cancer and its inhibition can be enhanced with embelin co-treatment
    Abdul Khalid Siraj et al, 2018, Oncotarget CrossRef
14. High PARP-1 expression is associated with tumor invasion and poor prognosis in gastric cancer
    Ying Liu et al, 2016, Oncology Letters CrossRef
15. PARP1 in Carcinomas and PARP1 Inhibitors as Antineoplastic Drugs
    Luyao Wang et al, 2017, International Journal of Molecular Sciences CrossRef
16. PARP1 as a prognostic biomarker for human cancers: a meta-analysis
    Yan-Hua Huang et al, 2021, Biomarkers in Medicine CrossRef
17. PARP-1 Expression and BRCA1 Mutations in Breast Cancer Patients’ CTCs
    Thodoris Sklias et al, 2022, Cancers CrossRef
18. Assessment of PARP-1 Distribution in Tissues of Cynomolgus Monkeys
    Maria Tedim Ferreira et al, 2020, Journal of Histochemistry & Cytochemistry CrossRef
19. Transcriptional Regulation of CCL2 by PARP1 Is a Driver for Invasiveness in Breast Cancer
    Pranabananda Dutta et al, 2020, Cancers CrossRef
20. Polymorphisms in PARP1 predict disease-free survival of triple-negative breast cancer patients treated with anthracycline/taxane based adjuvant chemotherapy
    Yuqian Liao et al, 2020, Scientific Reports CrossRef
21. High Poly(ADP-Ribose) Polymerase Expression Does Relate to Poor Survival in Solid Cancers: A Systematic Review and Meta-Analysis
    Nishant Thakur et al, 2021, Cancers CrossRef
22. Proteomic analysis of the IPF mesenchymal progenitor cell nuclear proteome identifies abnormalities in key nodal proteins that underlie their fibrogenic phenotype
    Libang Yang et al, 2022, PROTEOMICS CrossRef